Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Advanced Multidisciplinary Research for Antimicrobial Resistance

Descrizione del progetto

Ricerca a lungo termine per combattere la resistenza agli antimicrobici

La resistenza agli antimicrobici (AMR, antimicrobial resistance) rappresenta una grave minaccia per la salute pubblica mondiale, tanto che l’Organizzazione mondiale della sanità l’ha classificata tra le 10 principali sfide globali. La pandemia di COVID-19 in corso ha ulteriormente sottolineato l’urgenza di affrontare questo problema, poiché amplifica il rischio di resistenza a causa dell’aumento dell’uso di farmaci antimicrobici. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto AMRAMR mira a promuovere una cooperazione di ricerca a lungo termine, concentrandosi sullo sviluppo di nanomateriali antibatterici innovativi, rivestimenti a film sottile, tecnologie di upconversion e fotonica e valutando le prestazioni antibatteriche per combattere la resistenza agli antimicrobici. Questo sforzo di collaborazione, della durata di 4 anni, coinvolge l’industria e le istituzioni accademiche in Europa, Cina e Stati Uniti.

Obiettivo

We are proposing a 4-year program of knowledge transfer and networking between academic institutions [University of Leicester (UK), University of Valencia (Spain), International Iberian Nanotechnology Lab (Portugal), University of Bologna (Italy), University of Aveiro (Portugal), Fudan University (China), and Alfred University (USA)] and industrial partners [Teer Coatings Ltd (UK)]. The objective of the proposed joint exchange programme is to establish long-term stable research cooperation between the partners with interdisciplinary expertise and knowledge to develop Advanced Multidisciplinary Research for Antimicrobial Resistance (AMRAMR), including the development of novel antibacterial nanomaterials and nanostructures, novel antibacterial thin films coatings, upconversion technology for AMR applications, photonics technology for AMR application, and evaluation of the antibacterial performance and antimicrobial resistance; the synergetic effect for the above approaches to understanding antimicrobial resistance.

Antimicrobial resistance (AMR) refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of antimicrobial drugs, such as antibiotics, antivirals, antifungals, and antiparasitics. AMR is a serious global public health threat that could lead to increased morbidity, mortality, and healthcare costs.
World Health Organisation (WHO) has declared that AMR is one of the top 10 global public health threats facing humanity. The COVID-19 pandemic has highlighted the importance of AMR as it has led to increased use of antimicrobial drugs, particularly antibiotics, which can contribute to the development of AMR. People with COVID-19 may develop secondary bacterial infections, such as pneumonia, and may be prescribed antibiotics to treat these infections. However, unnecessary use of antibiotics can lead to the emergence and spread of resistant bacteria, making it more difficult to treat infections in the future.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Coordinatore

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Contributo netto dell'UE
€ 92 000,00
Indirizzo
VIA ZAMBONI 33
40126 Bologna
Italia

Mostra sulla mappa

Regione
Nord-Est Emilia-Romagna Bologna
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Partecipanti (3)

Partner (4)